UNICAM - Home - Welcome - Program - Abstracts - Registration&Accommodation - How to get here  - Committees - Contact us

28th Camerino-Cyprus-Noordwijkerhout Symposium

Camerino, May 16-20, 2010

Trekking through Receptor Chemistry

Program

Sunday, May 16th, 2010
Welcome
18:45 - M. Giannella (University of Camerino, I)
Opening lecture
19:00 - U. Hacksell (ACADIA Pharmaceuticals San Diego, USA) Discovery and development of drugs for CNS diseases

20:30 - Welcome dinner

*******

Monday (morning), May 17th, 2010

9:00-9:10 - Starting on the right foot: selection criteria in lead discovery (Chairman R. Thomas, I)
9:10-9:40 - R. E. Hubbard (University of York, Cambridge, UK) - Too much choice: selecting which fragments to optimize
9:40-10:10 - E. H. Kerns (Wyeth Research, Princeton, USA) Integration of drug-like properties in selection, optimization and biological assessment in lead discovery
10:10-10:30 – Coffee break
10:30-11:00 - C. Ghiron (Siena Biotech, Siena, I) The design, management and maintenance of a screening collection
11:00-11:30 - P. Leeson (Astra Zeneca, SE) Can We Improve ‘Compound Quality’?


12:30 Lunch

*******

Monday (afternoon), May 17th, 2010


15:00-15:10 – New avenues to target G protein coupled receptors (Chairman R. Leurs, NL)
15:10-15:40 – M. Bouvier (University of Montreal, CA) Ligand-based GPCR signalling; potential implications for drug discovery
15:40-16:10 – G. Zaman (Schering-Plough Research Institute, NL) New avenues to target 7-transmembrane receptors
16:10-16:30 – Coffee break
16:30-17:00 – M. Allegretti (R&D Dompι, I) Pharmacological characterization of functionally selective CXCR inhibitors
17:00-17:30 – M. Smit (LACDR, NL) Nanobodies as new GPCR modulators
17:30-18:00 – S. Schann (Domain Therapeutics, F) mGluR4 positive allosteric modulator: new paradigm for CNS indication treatment
18:00-18:30 – R. Pellicciari (University of Perugia, I) Prospects for a TGR5-mediated control of glucose homeostasis: focus on the clinical candidate S-EMCA (INT-777)

19:30 – Dinner

21:00 – Social event

*******

Tuesday (morning), May 18th, 2010


9:00-9:10 - G protein coupled receptors: old landscape with new eyes (Chairman D. Donati, I)
9:10-9:40 - G. Whitlock (Pfizer, UK) Design of BBB penetrant alpha1A receptor partial agonists
9:40-10:10 - C. Enzensperger (University of Jena, D) The dopamine D1-family: steps towards selectivity
10:10-10:30 - Coffee break
10:30-11:00 - A. Makriyannis (CY) The endocannabinoid proteins as drug targets
11:00-11:30 - D. Piomelli (University of Irvine, USA) The endocannabinoid system in the control of pain and emotion
11:30-12:00 - S. Ronzoni (NiKem Research, I) Novel potent and selective ORL-1 antagonists with efficacy in animal models of Parkinson's disease and neuropathic pain
12:00-12:30 – P. S. Portoghese (University of Minnesota, USA) Relevance of GPCR heteromers in the action of opioid analgesics

12:30 Lunch

*******

Tuesday (afternoon), May 18th, 2010


15:00-15:10 – Applications of computational methods in lead discovery
15:10-15:40 – M. S. Congreve (Heptares Therapeutics Ltd., UK) Stabilized GPCRs for structure based drug design
15:40-16:10 – K.-H. Baringhaus (Sanofi-Aventis, Detschland GmbH, D) Computer-assisted lead finding of GPCR and ion channel modulators
16:10-16:30 – Coffee break
16:30-16:40 – Receptors and beyond (Chairman R.A. Glennon, USA)
16:40-17:10 – P. J. L. Svenningsson (Karolinska University of Stockholm, SE ) Regulation of 5-HT receptors by p11
17:10-17:40 – E. X. Albuquerque (Uiversity of Maryland, USA) Nicotinic receptor function in the mammalian brain: modulatory properties and influence of endogenous regulators
17:40-18:10 – M. K. Schulte (University of Alaska Fairbanks, USA) Allosteric modulation of neuronal nicotinic acetylcholine receptors
18:10-18:40 – K. Mohr (University of Bonn, D) Dualsteric GPCR-targeting: Fine-tuning binding selectivity and signalling pathway activation

19:30 – Dinner

21:00 – Social event

*******

Wednesday (morning), May 19th, 2010


9:00-9:10 - Polypharmacology: creating selective non-selectivity (Chairmen C. Melchiorre / M.L. Bolognesi I)
9:10-9:40 - J. S. Mason (Lundbeck Research, DK) Polypharmacology: using it to differentiate and as an advantage with selective non-selectivity
9:40-10:10 - R. Morphy (Schering-Plough, UK) Multi-target drug discovery - past, present and future
10:10-10:30 - Coffee break
10:30-11:00 - C. J. Van der Schyf (NEOUCOM, USA) Multiple mechanism drugs for neurodegenerative diseases and post-stroke neuroprotection
11:00-11:30 - M. B. H. Youdim (University of Haifa, IL) Multimodal neurorestorative drugs acting at different brain regions and neuronal sites for neurodegenerative disorders

12:30 Lunch

*******

Wednesday (afternoon), May 19th, 2010


15:00-15:10 – Orexin antagonists as novel treatment of insomnia (Chairman H. Timmerman, NL)
15:10-15:40 – E. Ratti (GSK, I) Biology of the orexin system: focus on sleep-related mechanisms
15:40-16:10 – R. Di Fabio (GSK, I) Discovery of SB648868 as novel orexin receptor antagonists for treatment of insomnia
16:10-16:30 – Coffee break
16:30-17:00 – A. J. Roecker (MERK & Co., USA) Discovery of potent diazepane-containing dual orexin receptor antagonists for the treatment of insomnia
17:00-17:30 – C. Boss (Actelion Pharmaceuticals, CH) Orexin receptor antagonists - A new therapeutic principle in CNS disorders?
17:30-19:00 – Poster session

19:30 – Dinner

21:00 – Social event


*******

Thursday (morning), May 20th, 2010


9:00-9:10 - Application of stem cell technology to drug discovery (Chairman A. Makriyannis, USA)
9:10-9:40 - A. T. T. Chuang (GSK, USA) Application of stem cell technology in drug discovery
9:40-10:10 - A. Bakker (Siena Biotech, I) Brain tumor stem cells as a tool to identify novel therapeutics
10:10-10:30 - Coffee break
10:30-11:00 - R. Thomas (Siena Biotech, I) Successful modulation of tumor stem cells with small molecule hedgehog pathway antagonists
11:00-11:30 - G. Gaviraghi (Siena Biotech, I) Therapeutic modulation of the Wnt signalling pathway, an innovative approach for oncology and neurodegeneration
11:30-12:00 – Looking forward (M. Giannella - I, A. Makriyannis - CY, H. Timmerman - NL)
12:00-12:30 – D. J. Triggle (USA) The sustainability of pharmaceuticals in the 21st century: the idle thoughts of an idle fellow

12:30 Lunch


*******

Thursday (afternoon), May 20th, 2010

15:00 Trip to Matelica and Visit to the Museo Archeologico and Museo Piersanti; Visit to Lanciano Castle

21:00 Social dinner (Villa Fornari)
 



European Federation of Medicinal Chemistry


Medicinal Chemistry Division of the Italian Chemical Society

Info: secretariat.camerino@unicam.it